Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease

Background/Aims: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with Crohn’s disease (CD) are rare, particularly for Asian patients. We compared the key clinical outcomes (surgery, hospitalization, and corticosteroid use) of use of these two drugs in biolog...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Gastroenterology Council for Gut and Liver 2021-01-01
Edice:	Gut and Liver
Témata:	crohn disease infliximab adalimumab
On-line přístup:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl19377
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!